Barclays’s Kewaunee Scientific KEQU Stock Holding History

Barclays’s Portfolio KEQU Stock Details KEQU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.2K	Sell	680 -1,457	-68%	-$54.1K	﹤0.01%	4550
2026 Q1	$73.2K	Sell	2,137 -320	-13%	-$12.4K	﹤0.01%	4160
2025 Q4	$91.9K	Buy	+2,457	New	+$99.9K	﹤0.01%	4604
2025 Q2	–	Sell	-101	Closed	-$3.98K	–	5410
2025 Q1	$3.98K	Sell	101 -2,152	-96%	-$120K	﹤0.01%	4950
2024 Q4	$139K	Sell	2,253 -1,368	-38%	-$55.7K	﹤0.01%	4486
2024 Q3	$121K	Buy	+3,621	New	+$170K	﹤0.01%	4520
2020 Q1	–	Sell	-1	Closed	–	–	6310
2019 Q4	$0	Sell	1 -4	-80%	-$63	﹤0.01%	6581
2019 Q3	$0	Buy	+5	New	+$84	﹤0.01%	6921

Other funds holding KEQU

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DLP

De Lisle Partners Poole, United Kingdom $916M AUM 54.05% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's KEQU Position: Q2 2026 in Review

Barclays reduced its Kewaunee Scientific (KEQU) stake by 68% in Q2 2026, selling an estimated $54.1K and leaving 680 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4550.

Barclays first reported a position in KEQU in Q3 2019 and has held it in 8 quarters since. The position peaked at $139K in Q4 2024. 32 funds tracked by Wall St. Rank hold KEQU as of Q2 2026.

Barclays held 680 shares of Kewaunee Scientific worth $24.2K as of Q2 2026.
Barclays sold 1,457 Kewaunee Scientific shares in Q2 2026, an estimated $54.1K.
Kewaunee Scientific made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4550 holding.
Barclays first reported a position in Kewaunee Scientific in Q3 2019 and has held it in 8 quarters since.
Barclays's Kewaunee Scientific position peaked at $139K in Q4 2024.
32 funds tracked by Wall St. Rank held Kewaunee Scientific as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.